About
Ocular Transplant Therapies
Areas of Focus
Categories
Biologics & BiopharmaceuticalStem Cell & Cellular TherapySeattle/Pacific Northwest
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
147
By Phase
PHASE2: 1PHASE1/PHASE2: 1PHASE1: 1
By Status
ACTIVE_NOT_RECRUITING: 2COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06630169Lead Sponsor
Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction
PHASE2Active, not recruiting
25 participants
Started: Sep 16, 2024 · Completed: Oct 31, 2025
NCT06041256Lead Sponsor
A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)
PHASE1/PHASE2Active, not recruiting
100 participants
Started: Oct 18, 2023 · Completed: Oct 31, 2025
NCT05309135Lead Sponsor
A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial Dysfunction
PHASE1Completed
22 participants
Started: Mar 24, 2022 · Completed: Mar 9, 2023
Locations (1)
Headquarters
Seattle, WA, United States
Map
Loading map...